Municipal Employees Retirement System of Michigan Purchases 8,530 Shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART)

Municipal Employees Retirement System of Michigan increased its stake in Integra LifeSciences Holdings Corporation (NASDAQ:IART) by 62.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 22,200 shares of the life sciences company’s stock after buying an additional 8,530 shares during the period. Municipal Employees Retirement System of Michigan’s holdings in Integra LifeSciences Holdings Corporation were worth $1,210,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the company. Northwest Investment Counselors LLC raised its position in shares of Integra LifeSciences Holdings Corporation by 100.0% in the first quarter. Northwest Investment Counselors LLC now owns 7,880 shares of the life sciences company’s stock worth $332,000 after buying an additional 3,940 shares during the period. Diversified Trust Co raised its position in Integra LifeSciences Holdings Corporation by 105.3% in the first quarter. Diversified Trust Co now owns 13,550 shares of the life sciences company’s stock worth $571,000 after buying an additional 6,950 shares during the last quarter. State of Alaska Department of Revenue raised its position in Integra LifeSciences Holdings Corporation by 105.3% in the first quarter. State of Alaska Department of Revenue now owns 6,630 shares of the life sciences company’s stock worth $279,000 after buying an additional 3,400 shares during the last quarter. Columbus Circle Investors purchased a new position in Integra LifeSciences Holdings Corporation during the first quarter worth about $18,875,000. Finally, Nisa Investment Advisors LLC raised its position in Integra LifeSciences Holdings Corporation by 97.8% in the first quarter. Nisa Investment Advisors LLC now owns 24,920 shares of the life sciences company’s stock worth $1,050,000 after buying an additional 12,320 shares during the last quarter. 85.66% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Integra LifeSciences Holdings Corporation (NASDAQ IART) traded up 1.13% during midday trading on Friday, reaching $50.22. The company’s stock had a trading volume of 578,310 shares. The stock has a 50-day moving average of $52.04 and a 200 day moving average of $47.26. The company has a market cap of $3.92 billion, a price-to-earnings ratio of 61.24 and a beta of 0.73. Integra LifeSciences Holdings Corporation has a 12 month low of $37.71 and a 12 month high of $56.42.

Integra LifeSciences Holdings Corporation (NASDAQ:IART) last announced its quarterly earnings results on Wednesday, July 26th. The life sciences company reported $0.45 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.45. Integra LifeSciences Holdings Corporation had a return on equity of 16.79% and a net margin of 6.27%. The company had revenue of $282.16 million during the quarter, compared to the consensus estimate of $283.58 million. During the same period in the prior year, the company earned $0.40 earnings per share. The company’s revenue for the quarter was up 13.2% compared to the same quarter last year. On average, analysts predict that Integra LifeSciences Holdings Corporation will post $1.90 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Municipal Employees Retirement System of Michigan Purchases 8,530 Shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART)” was reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this report on another domain, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this report can be read at https://www.com-unik.info/2017/08/19/municipal-employees-retirement-system-of-michigan-buys-8530-shares-of-integra-lifesciences-holdings-corporation-nasdaqiart-updated.html.

A number of research analysts recently issued reports on the company. Oppenheimer Holdings, Inc. set a $60.00 target price on Integra LifeSciences Holdings Corporation and gave the stock a “buy” rating in a report on Saturday, June 24th. UBS AG reaffirmed a “buy” rating and set a $60.00 target price (up from $48.00) on shares of Integra LifeSciences Holdings Corporation in a report on Friday, June 9th. Raymond James Financial, Inc. increased their price target on Integra LifeSciences Holdings Corporation from $51.00 to $55.00 and gave the company an “outperform” rating in a research report on Thursday, July 27th. Zacks Investment Research lowered Integra LifeSciences Holdings Corporation from a “hold” rating to a “sell” rating in a research report on Wednesday, June 28th. Finally, Cantor Fitzgerald set a $65.00 price target on Integra LifeSciences Holdings Corporation and gave the company a “buy” rating in a research report on Wednesday, July 26th. Five analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $52.63.

In other Integra LifeSciences Holdings Corporation news, Director Barbara B. Hill purchased 5,050 shares of the stock in a transaction on Tuesday, August 1st. The stock was bought at an average cost of $49.33 per share, for a total transaction of $249,116.50. Following the completion of the acquisition, the director now directly owns 44,772 shares of the company’s stock, valued at $2,208,602.76. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Donald E. Morel, Jr. purchased 10,000 shares of the stock in a transaction on Friday, August 4th. The stock was acquired at an average price of $49.25 per share, with a total value of $492,500.00. Following the completion of the acquisition, the director now directly owns 29,612 shares of the company’s stock, valued at $1,458,391. The disclosure for this purchase can be found here. Insiders acquired 17,550 shares of company stock valued at $864,842 over the last 90 days. Corporate insiders own 21.50% of the company’s stock.

About Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing, and marketing of surgical implants and medical instruments. Its segments include Specialty Surgical Solutions, which offers specialty surgical instrumentation for a range of specialties, including product portfolio used in the neurosurgery operating suite and critical care unit, and Orthopedics and Tissue Technologies, which includes differentiated soft tissue repair and tissue regeneration products, and small bone fixation and joint replacement solutions.

Institutional Ownership by Quarter for Integra LifeSciences Holdings Corporation (NASDAQ:IART)

What are top analysts saying about Integra LifeSciences Holdings Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Integra LifeSciences Holdings Corporation and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit